CRK5

CRK5 (PF3D7_0615500) is a CDK-related protein kinase that drives DNA replication during male gametogony and is specifically required for mosquito transmission of Plasmodium (PMID:32568069, PMID:36154191). Originally characterized in P. falciparum as a 288-residue kinase active against casein and histone H1 in vitro and expressed at approximately constant levels in the cytosol across the asexual erythrocytic cycle (PMID:8143724), CRK5 acts as a functionally divergent CDK: in P. berghei it forms a stable complex with the Plasmodium-specific cyclin SOC2 and phosphorylates canonical CDK motifs on pre-replicative complex components to license DNA replication during the atypical mitosis of male gametogony, with its genetic disruption abolishing transmission (PMID:32568069). Consistent with this stage-restricted role, deletion of CRK5 in P. falciparum leaves asexual growth and gametocyte maturation to stage V intact but severely impairs male gametogenesis (reduced exflagellation) without affecting female fertility (PMID:36154191). The kinase carries an apicomplexan-specific PTxC activation-loop motif that distinguishes it from other CDKs (PMID:22047078). Beyond its SOC2 partnership and pre-replicative complex substrates, the structural basis of CRK5 activation and its full substrate repertoire have not been characterized in the available corpus.

1. 1994 Medium

   Establishing that PF3D7_0615500 encodes a bona fide protein kinase answered whether the gene product had catalytic activity and where it resides in the parasite.

   Evidence Heterologous E. coli expression, in vitro kinase assay on casein and histone H1, and antibody-based fractionation across the asexual cycle in P. falciparum

   PMID:8143724

   Open questions at the time

   • Substrate identity in vivo unknown
   • No regulatory partner identified
   • Generic substrates (casein, H1) do not indicate physiological targets
2. 1994 Low

   Testing whether CRK5 could substitute for cell-cycle CDKs in yeast addressed its functional conservation, but the result was inconclusive.

   Evidence Yeast cdc2/28 complementation assay with western-blot confirmation attempt in P. falciparum

   PMID:8143724

   Open questions at the time

   • Negative result confounded by undetectable expression of CRK5 in yeast
   • Does not exclude cell-cycle function
   • Single method
3. 2011 Low

   Comparative sequence analysis asked what makes apicomplexan CDKs distinct and identified a lineage-specific activation-loop feature in CRK5.

   Evidence Bayesian evolutionary and sequence/structural analysis of CDKs across 15 apicomplexan species identifying a PTxC activation-loop motif

   PMID:22047078

   Open questions at the time

   • Purely computational; PTxC motif function not experimentally validated
   • No link to a specific regulatory mechanism demonstrated
4. 2020 High

   Identifying CRK5's cyclin partner and substrates answered how the kinase is organized into a complex and what it does during the sexual stage, defining its role in DNA replication and transmission.

   Evidence Reciprocal Co-IP with cyclin SOC2, phosphoproteomics of pre-replicative complex substrates, and conditional knockout with DNA replication, exflagellation, and mosquito transmission readouts in P. berghei

   PMID:32568069

   Open questions at the time

   • Mechanism of CRK5/SOC2 activation without cyclin cycling unresolved
   • Structural basis of the divergent complex unknown
   • Full substrate repertoire beyond pre-replicative complex not defined
5. 2022 High

   Deletion in P. falciparum resolved the stage- and sex-specificity of CRK5, confirming its requirement for male gametogenesis and transmission rather than asexual growth.

   Evidence Pfcrk5 gene deletion with exflagellation assays, sex-specific genetic crosses, and mosquito transmission assays in P. falciparum

   PMID:36154191

   Open questions at the time

   • Molecular substrates driving the male-specific defect in P. falciparum not directly mapped
   • Whether SOC2 partnership is conserved in P. falciparum not tested here

• How the PTxC-containing CRK5/SOC2 complex is activated in the absence of conventional cyclin cycling, and its complete substrate network across the male gametogony transition, remain open.
• No structural model of CRK5 or its complex
• Activation mechanism without cyclin oscillation undefined
• Substrate repertoire outside pre-replicative complex uncharacterized